A Randomized, Double‐Blind, Placebo‐Controlled Trial of a Novel Recombinant, Humanized, Anti‐Interleukin‐13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study: 420. (October 2016) - Dellon, Evan S.; Collins, Margaret; Assouline‐Dayan, Yehudith; Evans, Larry; Gupta, Sandeep K.; Schoepfer, Alain; Straumann, Alex; Grimm, Michael; Smith, Heather; Tompkins, Cindy‐ann; Woo, Amy; Peach, Robert; et al.